Table 3 Characteristics of the COVID-19 cohort at baseline and follow-up
From: Long-term cardiac pathology in individuals with mild initial COVID-19 illness
Characteristic | Baseline n = 346 | Follow-up n = 346 | Adjusted difference | 95% CI | P value |
|---|---|---|---|---|---|
Days from diagnosis | 109 (77, 177) | 329 (274, 383) | |||
Heart rate (bpm) | 70 ± 11 | 68 ± 11 | 1.7 | 0.49, 2.8 | 0.006 |
Systolic BP (mmHg) | 132 ± 17 | 128 ± 17 | 2.5 | 0.72, 4.2 | 0.006 |
Diastolic BP (mmHg) | 83 ± 11 | 82 ± 12 | 0.62 | −0.60, 1.9 | 0.318 |
CRP (mg dl−1) | 0.1 (0.0, 0.2) | 0.1 (0.0, 0.2) | −0.16 | −0.46, 0.13 | 0.280 |
hs-TropT (pg ml−1) | 4.1 (3.0, 5.8) | 3.6 (3.0, 5.7) | 0.09 | −0.20, 0.37 | 0.550 |
NT-proBNP (pg ml−1) | 43.5 (23.6, 78.6) | 41.0 (21.0, 75.0) | 0.73 | −3.9, 5.4 | 0.757 |
LVEF (%) | 56.6 ± 4.6 | 56.9 ± 4.8 | −0.25 | −0.75, 0.24 | 0.318 |
GLS (%) | −19.4 ± 3.1 | −18.7 ± 3.2 | −0.44 | −0.92, 0.04 | 0.070 |
LV-EDVi (ml m−2) | 86.3 ± 13.8 | 85.2 ± 13.9 | 0.75 | −0.72, 2.2 | 0.315 |
LV mass index (g m−2) | 47.0 ± 9.2 | 47.5 ± 9.2 | −0.39 | −1.4, 0.66 | 0.45 |
RVEF (%) | 54.0 ± 5.6 | 55.4 ± 5.6 | −1.0 | −1.6, −0.39 | 0.001 |
Native T1 (ms) | 1129 ± 34 | 1122 ± 28 | 5.0 | 1.7, 8.3 | 0.003 |
Native T2 (ms) | 38.3 ± 1.7 | 37.7 ± 1.3 | 0.42 | 0.26, 0.58 | <0.001 |
